Local Navigation
Worldwide News
2008
- 26 JUNE 2008
Otsuka Pharmaceutical Co., Ltd. Announces the Appointment of New President - 26 JUNE 2008
Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors - 10 JUNE 2008
Otsuka and UCB agreed to co-develop and co-promote Keppra® and Cimzia® in Japan - 28 MAY 2008
Otsuka Pharmaceutical Co., Ltd. invests in French leading mineral water company, ALMA S.A. - 23 MAY 2008
(PDF) Otsuka Pharmaceutical Co., Ltd.- Fiscal Year through March 2008 – Parent Company Results - 23 MAY 2008
(PDF) Otsuka Pharmaceutical Co., Ltd.-Fiscal Year through March 2008 – Consolidated Results - 12 MAY 2008
Abilify®(aripiprazole) Receives Expanded Indications for Maintenance Treatment in both Pediatric Patients(Aged 10-17) with Manic and Mixed Episodes of Bipolar I Disorder and Adolescents(Aged 13-17) with Schizophrenia - 12 MAY 2008
U.S. Food and Drug Administration Approves Abilify®(aripiprazole) for Add-on Treatment to Lithium or Valproate in the Acute Treatment of Adults with Manic and Mixed Episodes of Bipolar I Disorder with or without Psychotic Features - 25 APR 2008
The Otsuka Pharmaceutical Group – First time exhibitor at the Hannover Messe. - 25 APR 2008
The rhythms of Japan – 50 dancers from Otsuka Pharmaceuticals perform the Awa Odori dance at the Hannover Messe Opening Ceremony. - 25 APR 2008
The first drug to be approved in Sweden for intermittent claudication:Pletal® is reimbursed - 09 APRIL 2008
Bristol-Myers Squibb and Otsuka Receive European Marketing Authorisation for Abilify® in the Treatment and Prevention of Moderate to Severe Manic Episodes in Bipolar I Disorder - 12 MAR 2008
Otsuka Pharmaceutical and PDL Biopharma Close Sale of IV Busulfex - 03 MAR 2008
U.S. Food and Drug Administration Approves Abilify®(aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated with Bipolar I Disorder in Pediatric Patients(10 to 17 Years of Age) - 26 FEB 2008
Bristol-Myers Squibb and Otsuka Receive Positive CHMP Opinion for Abilify® (aripiprazole) in Bipolar I Disporder
2007
- 21 DEC 2007
New Drug Application for Tolvaptan, Otsuka's Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by The U.S. Food and Drug Administration - 18 DEC 2007
Otsuka Pharmaceutical Acquires Rights to IV Busulfex from PDL Biopharma - 21 NOV 2007
U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) as the First Medication for Add-On Treatment of Major Depressive Disorder (MDD) - 9 JUL 2007
GW and Otsuka Enter into Global Cannabinoid Research Collaboration - 26 JUN 2007
New Symbol Signifying Otsuka Pharmaceutical's Corporate Philosophy Introduced on June 26, 2007 - 25 JUN 2007
(PDF) Otsuka Pharmaceutical Co., Ltd.- Financial Results for the Year ended March 31, 2007 - 15 MAY 2007
SOYJOY Fruit Soy Bar launched in Taiwan by Otsuka Pharmaceutical affiliate, King Car Otsuka Co., Ltd. - 24 APR 2007
The Pharmaceutical Society of Japan Award for Drug Research and Development '07 received for antipsychotic drug "aripiprazole" - 10 APR 2007
Fruit Soy Bar SOYJOY launched nationwide in US by Otsuka Pharmaceutical subsidiary, Pharmavite LLC - 14 FEB 2007
GW and Otsuka Announce Major Long Term Strategic Cannabinoid Alliance - 24 JAN 2007
Otsuka Pharmaceutical Co., Ltd. Announces Establishment of New Organization - 23 JAN 2007
Otsuka Pharmaceutical Co., Ltd Announces VV Food & Beverage Co., Ltd. Launches Fruits Soy Bar SOY JOY in China - 5 JAN 2007
Otsuka Pharmaceutical Europe and Schwarz Pharma Deutschland to Co-promote Antiplatelet Agent Pletal® in Germany
2006
- 12 DEC 2006
Antiplatelet Agent “Pletaal®” Co-Promotion Agreement between Otsuka Pharmaceutical and Chugai Pharmaceutical - 5 DEC 2006
Results of the SALT-1 and SALT-2 Trials Show Tolvaptan Improves Serum Sodium Levels in Patients with Hyponatremia - 18 AUG 2006
BRISTOL-MYERS SQUIBB AND OTSUKA PHARMACEUTICAL COMPANY LAUNCH NEW RAPIDLY DISINTEGRATING ORAL ANTIPSYCHOTIC MEDICATION ABILIFY® DISCMELT™ (aripiprazole) - 23 JUN 2006
SINVINO GOLD & RED Brand New Alcohol Free Sparkling Experience - 16 JUN 2006
Prix Galien awarded to Abilify® (aripiprazole) for medical innovation - 6 JUN 2006
Drug to treat schizophrenia with a new mechanism of action Antipsychotic agent "Abilify®" Available in Japan from June 8 - 19 APR 2006
“The 15th Asian Games Doha 2006” POCARI SWEAT announced as the official sports drink for Doha 2006 - 10 MAR 2006
ENJOY SINVINO! Non-alcoholic sparkling beverage for adults “SINVINO SPARKLING GOLD & RED” 300 ML BOTTLE - On sale from Monday, March 27 - - 28 FEB 2006
A new portable form of soybeans FRUIT SOY BAR “SOYJOY” To be released on April 3 - 25 JAN 2006
Otsuka's Antipsychotic Abilify® Is Approved in Japan, January 23, 2006
Back to top